News
{"cpt":"blog","style":"1","columns":"3","show":9,"order":"DESC","orderby":"none"}
25 Feb, 2025
Quick Start: How the right partner can fast-track your pharmaceutical development and market entry
The complex journey of bringing a pharmaceutical product to market requires…
13 Nov, 2024
CMC Pharma Extends Shelf-life of Key Prophylactic, Receives FDA Approval
CMC Pharmaceuticals Successfully Extends Operational Shelf-life of Medical Countermeasure, Receives FDA…
12 Sep, 2024
A Growing Nerve Agent Defense Portfolio
CMC Pharma Subcontracted for Nerve Agent Countermeasure Development Program by Battelle…
20 Nov, 2023
Recent FDA Inspection Supports GMP Testing Services
Recent FDA Inspection Supports Offered cGMP Testing Services CMC Pharmaceuticals recently…
6 Dec, 2022
CMC Pharmaceuticals Continues Development of Medical Countermeasures
CMC Pharmaceuticals Awarded Sequential Phase II SBIR Grant to Continue Pharmaceutical…
16 Nov, 2022
PODD: Partnership Opportunities in Drug Delivery – 2022 Conference Recap
After a long couple of years and many virtual conferences, the…
7 Jun, 2022
The Importance of Stability Studies in Pharmaceuticals
The Importance of Stability Studies in Pharmaceuticals Stability studies in pharmaceuticals…
5 May, 2022
CMC Pharmaceuticals Expands Chemical Defense Portfolio
Department of Defense Awards CMC Pharma SBIR Grant, Adding to Existing…
6 Apr, 2022
CMC Pharmaceuticals Awarded SBIR Grant For Concentrated Atropine Formulation
CMC Pharmaceuticals Awarded SBIR Grant For Concentrated Atropine Formulation Solon, OH: CMC…